Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

被引：1257

作者：

van Dam, Gooitzen M. ^{[1
]}

Themelis, George ^{[2
,3
]}

Crane, Lucia M. A. ^{[1
]}

Harlaar, Niels J. ^{[1
,2
,3
]}

Pleijhuis, Rick G. ^{[1
]}

Kelder, Wendy ^{[1
]}

Sarantopoulos, Athanasios ^{[2
,3
]}

de Jong, Johannes S. ^{[1
]}

Arts, Henriette J. G. ^{[4
]}

van der Zee, Ate G. J. ^{[4
]}

Bart, Joost ^{[5
]}

Low, Philip S. ^{[6
]}

Ntziachristos, Vasilis ^{[2
,3
]}

机构：

[1] Univ Groningen, BioOpt Imaging Ctr, Div Surg Oncol, Dept Surg, Groningen, Netherlands

[2] Tech Univ Munich, Munich, Germany

[3] Helmholtz Zentrum, Munich, Germany

[4] Univ Groningen, Div Gynaecol Oncol, Dept Gynaecol, Groningen, Netherlands

[5] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Mol Biol, Groningen, Netherlands

[6] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA

来源：

NATURE MEDICINE | 2011年 / 17卷 / 10期

关键词：

SURGERY; EXPRESSION; MANAGEMENT; SURVIVAL; FUTURE; MODEL;

D O I：

10.1038/nm.2472

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The prognosis in advanced-stage ovarian cancer remains poor. Tumor-specific intraoperative fluorescence imaging may improve staging and debulking efforts in cytoreductive surgery and thereby improve prognosis. The overexpression of folate receptor-alpha (FR-alpha) in 90-95% of epithelial ovarian cancers prompted the investigation of intraoperative tumor-specific fluorescence imaging in ovarian cancer surgery using an FR-alpha-targeted fluorescent agent. In patients with ovarian cancer, intraoperative tumor-specific fluorescence imaging with an FR-alpha-targeted fluorescent agent showcased the potential applications in patients with ovarian cancer for improved intraoperative staging and more radical cytoreductive surgery.

引用

页码：1315 / U202

页数：6

共 32 条

[1] Aggressive surgical effort and improved survival in advanced-stage ovarian cancer
Aletti, GD
Dowdy, SC
Gostout, BS
Jones, MB
Stanhope, CR
Wilson, TO
Podratz, KC
Cliby, WA
[J]. OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) : 77 - 85
[2] Aletti GD, 2007, MAYO CLIN PROC, V82, P751
[3] Exploratory phase II efficacy study of MORAb-003, a monoclonal antibody against folate receptor alpha, in platinum-sensitive ovarian cancer in first relapse
Armstrong, D. K.
Bicher, A.
Coleman, R. L.
Gibbon, D. G.
Glenn, D.
Old, L.
Senzer, N. N.
Schneeweiss, A.
Verheijen, R. H.
White, A. J.
Weil, S.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
[4] Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209
[5] The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer
Crane, Lucia M. A.
Arts, Henriette J. G.
van Oosten, Marleen
Low, Philip S.
van der Zee, Ate G. J.
van Dam, Gooitzen M.
Bart, Joost
[J]. CELLULAR ONCOLOGY, 2012, 35 (01) : 9 - 18
[6] Trends in cancer survival in 11 European populations from 1990 to 2009: a model-based analysis
Gondos, A.
Bray, F.
Hakulinen, T.
Brenner, H.
[J]. ANNALS OF ONCOLOGY, 2009, 20 (03) : 564 - 573
[7] Predicting the Outcome of Cytoreductive Surgery for Advanced Ovarian Cancer A Review
Ibeanu, Okechukwu A.
Bristow, Robert E.
[J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 : S1 - S11
[8] Cancer statistics, 2008
Jemal, Ahmedin
Siegel, Rebecca
Ward, Elizabeth
Hao, Yongping
Xu, Jiaquan
Murray, Taylor
Thun, Michael J.
[J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2008, 58 (02) : 71 - 96
[9] Folate receptor alpha as a tumor target in epithelial ovarian cancer
Kalli, Kimberly R.
Oberg, Ann L.
Keeney, Gary L.
Christianson, Teresa J. H.
Low, Philip S.
Knutson, Keith L.
Hartmann, Lynn C.
[J]. GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : 619 - 626
[10] Optical imaging of metastatic tumors using a folate-targeted fluorescent probe
Kennedy, MD
Jallad, KN
Thompson, DH
Ben-Amotz, D
Low, PS
[J]. JOURNAL OF BIOMEDICAL OPTICS, 2003, 8 (04) : 636 - 641

← 1 2 3 4 →